Home

The health system in Holguín province is promoting an investment program that contributes to improving the quality of services to the population and the working conditions of health professionals as one of the priorities of the sector in Cuba.

Some 30 individuals between 19 and 59 years of age have traveled from Italy to Cuba to take part as volunteers in the Soberana Plus Turin clinical trial, being conducted by institutions in the two countries.

Researchers at the Center for Genetic Engineering and Biotechnology (CIGB) plan to submit the dossier of the Cuban vaccine Abdala to the World Health Organization (WHO) in March, as part of the process to obtain its authorization for emergency use.